Inflammatory bowel disease (IBD) is a chronic immune-mediated disease affecting the
gastrointestinal tract. IBD consists of 2 subtypes: ulcerative colitis and Crohn disease. IBD is …

Host health depends on the intestinal homeostasis between the innate/adaptive immune
system and the microbiome. Numerous studies suggest that gut microbiota are constantly …

Many benefits provided by the gut microbiota to the host rely on its intricate interactions with
host cells. Perturbations of the gut microbiota, termed gut dysbiosis, affect the interplay …

The aetiology and pathogenesis of inflammatory bowel disease (IBD) remains unclear but
involves a complex interplay between genetic risk, environmental exposures, the immune …

The gastrointestinal (GI) tract is the residence of trillions of microorganisms that include
bacteria, archaea, fungi and viruses. The collective genomes of whole microbial …

Inflammatory bowel disease (IBD) is a chronic complex inflammatory gut pathological
condition, examples of which include Crohn's disease (CD) and ulcerative colitis (UC) …

The continuing identification of several epigenetic, transcriptomic, proteomic, and
metabolomic alterations in patients with IBD reflects the complex nature of the disease and …

Introduction Inflammatory bowel diseases (IBDs) and chronic rheumatic diseases (CRDs)
are systemic chronic disorders sharing common genetic, immune and environmental factors …

Inflammatory bowel disease (IBD) is thought to result from a dysregulated immune response
to intestinal microbial flora in individuals with genetic predisposition (s). Genome-wide …

The intestinal microbiota is a dynamic community of bacteria, fungi, and viruses that
mediates mucosal homeostasis and physiology. Imbalances in the microbiome and aberrant …